Mrna Encoding Human Cytomegalovirus Glycoprotein B, Mrna Encoding Human Cytomegalovirus Glycoprotein H, Mrna Encoding Human Cytomegalovirus Glycoprotein L, Mrna Encoding Human Cytomegalovirus Ul128, Mrna Encoding Human Cytomegalovirus Ul130, Mrna Encoding Human Cytomegalovirus Ul131A

1 trials

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

7 Countries

Phase III

Phase III: 1

Indications tested

Cytomegalovirus immunisation 1

Sponsors using this IMP

All trials

1 total

Evaluating the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age Ended

2023-508820-37-00 Phase III 7 countries Moderna Inc.

Showing 1–1 of 1 trials

← All drugs A–Z